Biomarin Pharmaceutical (BMRN) Stock Price
$68.25 0%
to add to portfolio
AI Score
-
Alternative
9 -
Fundamental
8 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Biomarin Pharmaceutical, AI stock picks, stock alerts and much more.
BMRN AI Stock Analysis
Financial Performance
Biomarin Pharmaceutical's financial performance shows a mixed picture. The company has managed to increase its revenue by 15.4% year over year, which is a positive sign. However, gross profit has slightly decreased by -1.2% from the previous quarter. A significant improvement was seen in operating income profit with an increase of 701% year over year, indicating the company's cost management and operational efficiency have improved significantly.
Stock Price
The stock price has been on a downtrend with a decrease of -32.1% year over year and -6.5% in the last month alone. This could be due to market sentiment or specific issues related to the company itself. The RSI value at 33 indicates that the stock is nearing oversold territory which might signal an upcoming reversal if other factors align positively.
Alternative Data Signals
The alternative data signals do not paint a very promising picture for Biomarin Pharmaceutical either, with web traffic decreasing by -25.5% YoY and only a small growth of followers on Facebook (1%). However, there is an increase in job postings which could indicate expansion plans or increased activity within the company.
Conclusion
In conclusion, while there are some positive signs such as increased revenue and operating income profit, overall the analysis leans more towards bearish due to declining stock price trends and negative alternative data signals.
Note: This AI Stock Analysis is based on data as of January 26. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Biomarin Pharmaceutical (BMRN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Biomarin Pharmaceutical (BMRN), currently trading at $68.25, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BMRN
-
BioMarin Pharmaceutical Inc.
-
Symbol
BMRN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
13B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
BMRN Alternative Data
Web Traffic
Biomarin Pharmaceutical receives an estimated 93367 monthly visitors to biomarin.com.
-
Web Traffic
93367
-
Change from Previous Month
90%
-
3 Month Change
67%
-
YoY Change
67%
News Mentions
Biomarin Pharmaceutical was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Biomarin Pharmaceutical has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
100%
Facebook Engagement
Biomarin Pharmaceutical has engaged 11 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
11
-
Daily Change
175%
-
1 Month Change
22.2%
-
3 Month Change
10%
-
YoY Change
10%
Youtube Subscribers
Biomarin Pharmaceutical has 1,860 subscribers on its main Youtube channel, up by 1.6% over the last month.
-
Youtube Subscribers
1860
-
Daily Change
0%
-
1 Month Change
1.6%
-
3 Month Change
4.5%
-
YoY Change
4.5%
LinkedIn Followers
181,262 are following Biomarin Pharmaceutical on LinkedIn, up by 1.7% over the last month.
-
LinkedIn Followers
181262
-
Daily Change
0%
-
1 Month Change
1.7%
-
3 Month Change
3.5%
Job Postings
Biomarin Pharmaceutical currenly has an estimated 130 open job postings, up by 21.5% over the last month.
-
Job Postings
130
-
Daily Change
1.5%
-
1 Month Change
21.5%
-
3 Month Change
56.6%
-
YoY Change
56.6%
LinkedIn Employees
According to LinkedIn, Biomarin Pharmaceutical has 3,123 employees, down by -0.9% over the last month.
-
LinkedIn Employees
3123
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
6.2%
-
YoY Change
6.2%
Business Outlook
-
Business Outlook
39
-
Change from Previous Month
20.4%
-
3 Month Change
0%
-
YoY Change
0%
Instagram Followers
Biomarin Pharmaceutical has 4,219 Instagram Followers on its main Instagram account.
-
Instagram Followers
4219
-
Daily Change
0.3%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
BMRN Financials
BMRN Key Metrics
-
Total Revenue
$733.9B
-
Net Income
$106.1B
-
Earnings per Share
$557.06
-
Free cash flow
$321.2B
-
EBITDA
$113.9B
-
EBITDA Ratio
0.155196
-
Total Assets
$6851.2B
BMRN 2-year Revenue & Income
BMRN 2-year Free Cash Flow
BMRN Technicals
BMRN SMA
BMRN RSI
FAQ
What's the current price of Biomarin Pharmaceutical (BMRN) Stock?
The price of an Biomarin Pharmaceutical (BMRN) share is $68.25.
What's the market cap of Biomarin Pharmaceutical?
The current market cap of Biomarin Pharmaceutical is 13B.
Should I buy or sell BMRN?
Biomarin Pharmaceutical shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Biomarin Pharmaceutical is better viewed as a hold or accumulate position while waiting for further developments.
Is Biomarin Pharmaceutical a good investment?
The current analysis of Biomarin Pharmaceutical's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Biomarin Pharmaceutical's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Biomarin Pharmaceutical (BMRN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Biomarin Pharmaceutical stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Biomarin Pharmaceutical (BMRN) that investors often compare it to?
Biomarin Pharmaceutical (BMRN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Biomarin Pharmaceutical's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Biomarin Pharmaceutical's stock price to be around $70.37 in 2026. Starting from the current price of $68.25, this represents a 3.1% change in price, indicating a neutral outlook for the stock.
How to buy Biomarin Pharmaceutical (BMRN) Stock?
Biomarin Pharmaceutical stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Biomarin Pharmaceutical shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.